Santarus Inc (SNTS)
Symbol Info
Listed Symbol SNTS
Name Santarus Inc
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2012-12-31
Latest Fiscal Revenue $217,955,000
Latest Fiscal EPS $0.27
Price Info
21 Day Moving Average $31.9438
21 Day EMA $31.792030
50 Day Moving Average $30.6524
50 Day EMA $30.328800
200 Day EMA $24.228590
200 Day Moving Average 24.163060
52 Week High $32.25
52 Week Low $10.93
52 Week Change $170.508500
Alpha 0.037945
Beta 1.7018
Standard Deviation 0.163010
R2 0.210487
Periods 60
Share Information
10 Day Average Volume 789,739
20 Day Average Volume 1,346,260
30 Day Average Volume 1,588,417
50 Day Average Volume 2,685,422
Outstanding Shares 67,326,021
Float Shares 67,326,021
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 259
Institute Holdings Date 2013-12-31
Institute Bought Previous 3 Months 23,006,466
Institute Holdings Percent 90.100000
Institute Sold Previous 3 Months 12,749,682
Insider Holdings Date 2013-11-30
Insider Bought Previous 3 Months 409,521
Insider Holdings Percent 1.80%
Insider Sold Previous 3 Months 479,049
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $-0.0100002
21 Day Percent Change -0.03%
30 Day Price Change $-0.0300007
30 Day Percent Change -0.09%
Month To Date Price Change $-0.04
Month To Date Percent -0.13%
90 Day Price Change $10.600000
90 Day Percent Change 49.72%
Quarter To Date $-0.039999
Quarter To Date Percent -0.13%
180 Day Price Change $8.590000
180 Day Percent Change 36.82%
200 Day Price Change $10.969999
200 Day Percent Change 52.36%
Year To Date $-0.039999
Year To Date Percent -0.13%
Profile
Description
Details
Issue Type CS
Market Cap $2,149,046,590
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding -
CEO
Employees 290
Last Audit UE
Classification
CIK 0001172480
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 3611 Valley Centre Drive
Suite 400
San Diego, CA 92130
Website http://www.santarus.com
Facisimile +1 858 314-5701
Telephone +1 858 314-5700
Email contact@santarus.com
Key Ratios
Profitability
EBIT Margin 22.00
EBITDA Margin 23.9
Pre-Tax Profit Margin 2.9
Profit Margin Cont 37.91
Gross Margin 67.10
Profit Margin TOT 37.91
Income Statements
Revenue $337,809,000
Revenue Per Share $5.0175
Revenue 3 Years $35.09
Revenue 5 Years $14.10
Valuation Measures
PE Ratio 19.50
Enterprise Value $-
Price To Sales 6.361722
Price To Free Cash 26.300000
PE High Last 5 Years -
Price To Book 9.4
Price To Cash Flow 16.0
PE Low Last 5 Years -
Price To Tangible Book 9.5
Financial Strength
Total Debt To Equity -
Int Coverage 254.2
Current Ratio 3.5
Leverage Ratio 1.5
Quick Ratio 2.8
Long Term Debt To Capital -
Assets
Receivables Turnover 9.1
Invoice Turnover 10.20
Assets Turnover 1.40
Management Effectiveness
Return Assets 41.09
Return On Equity 55.93
Return On Capital 55.93
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
SNTS
Santarus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.